Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

3 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
March 14, 2016 DCOY P 8,000 $9.13 $73,040 57,064 Direct +16.31% Acquired -100.0% (price as of 2026-10-02)
March 11, 2016 DCOY P 12,000 $7.15 $85,800 49,064 Direct +32.38% Acquired -100.0% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Jan. 17, 2018 DCOY Stock Option (right to buy) Common Stock (100,000) $3.98 Jan. 17, 2028 100,000 Acquired
Jan. 18, 2017 DCOY Stock Option (right to buy) Common Stock (85,000) $4.58 Jan. 18, 2027 85,000 Acquired
Jan. 21, 2016 DCOY Stock Option (right to buy) Common Stock (52,000) $9.59 Jan. 21, 2026 52,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
March 16, 2020 RLMD Options to purchase common stock→ Common Stock (350,000) 350,000 Direct
Jan. 28, 2015 DCOY Common Stock 37,064 Direct
Jan. 28, 2015 DCOY Stock Option (right to buy)→ Common Stock (126,072) 126,072 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

DCOY

M.D., Ph.D. Chief Medical Officer
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2017 $419,056 · · $255,689 $75,430 · $15,951 $766,126
2016 $406,850 · · · $138,329 · $13,187 $874,427
2015 $395,000 · · · $150,100 · $10,432 $1,713,798

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.